Intranasal Desmopressin vs IV Ketorolac in Renal Colic Pain Control

NCT02937896 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 40

Last updated 2016-10-19

No results posted yet for this study

Summary

The aim of this study is the comparison of efficacy of intravenous ketorolac and intranasal desmopressin in renal colic patients pain control.

Conditions

  • Renal Colic

Interventions

DRUG

Desmopressin

40 micrograms Nasal Desmopressin.

DRUG

Ketorolac

30mg intravenous Ketorolac.

DRUG

Normal Saline

1cc intravenous Normal Saline.

DRUG

Normal Saline

4 puffs nasal Normal Saline.

Sponsors & Collaborators

  • Shahid Beheshti University of Medical Sciences

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
16 Years
Max Age
50 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-01-31
Primary Completion
2016-02-29
Completion
2016-04-30

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02937896 on ClinicalTrials.gov